Literature DB >> 20653749

Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics.

A Ceriello1, K Esposito, M Ihnat, J Thorpe, D Giugliano.   

Abstract

OBJECTIVE: To investigate the possibility of reversing endothelial dysfunction and inflammation by glucose normalization, antioxidants and insulin per se, in different subgroups of Type 1 diabetic patients.
METHODS: Three subgroups of Type 1 diabetic patients were studied: patients within 1 month of diagnosis (subgroup 1); patients with approximately 5 years' disease duration and with glycated haemoglobin (HbA(1c)) <or= 7.0% (subgroup 2) or > 7.0% since diagnosis (subgroup 3). Participants underwent four procedures: 2-h hyperglycaemic clamp followed by: (A) 12 h near-normalization of blood glucose, with the addition of vitamin C during the last 6 h; (B) 12-h vitamin C and near-normalization of blood glucose for the last 6 h; (C) both vitamin C and near-normalization of blood glucose for 12 h; (D) hyperglycaemic-hyperinsulinaemic clamp for 12 h, with the addition of vitamin C during the last 6 h.
RESULTS: After 2 h of hyperglycaemia, markers of endothelial dysfunction, nitrotyrosine, 8-iso prostaglandin F2alpha, soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, interleukin (IL)-6 and IL-18 were increased in all the subgroups. Levels were normalized, at all time points, by treatments A, B and C in the subgroups 1 and 2. In the third subgroup, levels were normalized only by the simultaneous normalization of blood glucose and vitamin C treatment. During treatment D, the levels were improved at 6 h in all the subgroups, but normalized at 12 h only after vitamin C in subgroups 1 and 2, but not in subgroup 3.
CONCLUSIONS: This study suggests that different subgroups of Type 1 diabetic patients react identically to acute hyperglycaemia and insulin, but differently to glucose normalization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653749     DOI: 10.1111/j.1464-5491.2009.02928.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.

Authors:  Eun-Ah Ye; Li Liu; Jena J Steinle
Journal:  Vision Res       Date:  2017-08-07       Impact factor: 1.886

2.  Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis.

Authors:  Shao-gang Ma; Yue Jin; Wei Xu; Wen Hu; Feng Bai; Xiao-juan Wu
Journal:  Endocrine       Date:  2012-03-23       Impact factor: 3.633

3.  Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study.

Authors:  Karen M Rothacker; Sam Armstrong; Grant J Smith; Nat Benjanuvatra; Brendan Lay; Peter Adolfsson; Timothy W Jones; Paul A Fournier; Elizabeth A Davis
Journal:  Diabetologia       Date:  2021-05-04       Impact factor: 10.122

Review 4.  Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials.

Authors:  Markolf Hanefeld; Louis Monnier; Oliver Schnell; David Owens
Journal:  Diabetes Ther       Date:  2016-02-10       Impact factor: 2.945

5.  miR-15a/16 reduces retinal leukostasis through decreased pro-inflammatory signaling.

Authors:  Eun-Ah Ye; Li Liu; Youde Jiang; Jenny Jan; Subhash Gaddipati; Susmit Suvas; Jena J Steinle
Journal:  J Neuroinflammation       Date:  2016-12-08       Impact factor: 8.322

Review 6.  The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.

Authors:  Roberto Testa; Anna Rita Bonfigli; Francesco Prattichizzo; Lucia La Sala; Valeria De Nigris; Antonio Ceriello
Journal:  Nutrients       Date:  2017-04-28       Impact factor: 5.717

7.  Acute Hyperglycemia and Spatial Working Memory in Adolescents With Type 1 Diabetes.

Authors:  Jasna Šuput Omladič; Anka Slana Ozimič; Andrej Vovk; Dušan Šuput; Grega Repovš; Klemen Dovc; Nataša Bratina; Magdalena Avbelj Stefanija; Tadej Battelino
Journal:  Diabetes Care       Date:  2020-05-29       Impact factor: 19.112

Review 8.  Glycemic Variability and CNS Inflammation: Reviewing the Connection.

Authors:  Charles Watt; Elizabeth Sanchez-Rangel; Janice Jin Hwang
Journal:  Nutrients       Date:  2020-12-21       Impact factor: 5.717

9.  Non-invasive detection of coronary endothelial response to sequential handgrip exercise in coronary artery disease patients and healthy adults.

Authors:  Allison G Hays; Matthias Stuber; Glenn A Hirsch; Jing Yu; Michael Schär; Robert G Weiss; Gary Gerstenblith; Sebastian Kelle
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

10.  Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Authors:  Antonio Ceriello; Anna Novials; Emilio Ortega; Silvia Canivell; Lucia La Sala; Gemma Pujadas; Katherine Esposito; Dario Giugliano; Stefano Genovese
Journal:  Diabetes Care       Date:  2013-04-05       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.